13. 参考文献
1.
2.
3.
4.
5.
6.
7.
8.
9.
Screening for prostate cancer. UpToDate. last updated: 10 17, 2013.
平成19年度厚生労働省がん研究助成金「がん検診の適切な方法とその評価法の確立に関する
研究」班. 有効性評価に基づく前立腺がん検診ガイドライン. 2008.
http://minds.jcqhc.or.jp/n/med/4/med0061/G0000168/0001
厚生労働省. 平成25年度市区町村におけるがん検診の実施状況調査集計結果.
http://www.mhlw.go.jp/file.jsp?id=147922&name=0000013913.pdf
日本泌尿器科学会. 前立腺がん検診ガイドライン2010年増補版. 金原出版, 2009.
Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S.
Preventive Services Task Force recommendation statement. Ann Intern Med. 2012
Jul 17;157(2):120-34.
Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA
Guideline. J Urol. 2013 Aug;190(2):419-26. Epub 2013 May 6.
Schröder FH, Hugosson J, Roobol MJ, et al. ; ERSPC Investigators. Screening and
prostate-cancer mortality in a randomized European study. N Engl J Med. 2009
Mar 26;360(13):1320-8. Epub 2009 Mar 18.
Schröder FH, Hugosson J, Roobol MJ, et al. ; ERSPC Investigators. Prostatecancer mortality at 11 years of follow-up. N Engl J Med. 2012 Mar
15;366(11):981-90.
Andriole GL, Crawford ED, Grubb RL 3rd, et al. ; PLCO Project Team. Mortality
results from a randomized prostate-cancer screening trial. N Engl J Med. 2009
Mar 26;360(13):1310-9. Epub 2009 Mar 18.
14. 参考文献
10.
11.
12.
13.
14.
15.
16.
Ilic D, Neuberger MM, Djulbegovic M, et al. Screening for prostate cancer. Cochrane
Database Syst Rev. 2013 Jan 31;1:CD004720.
Wilt TJ, Brawer MK, Jones KM, et al. ; Prostate Cancer Intervention versus
Observation Trial (PIVOT) Study Group. Radical prostatectomy versus observation
for localized prostate cancer. N Engl J Med. 2012 Jul 19;367(3):203-13.
Johansson JE, Andrén O, Andersson SO, et al. Natural history of early, localized
prostate cancer. JAMA. 2004 Jun 9;291(22):2713-9.
Bill-Axelson A, Holmberg L, Ruutu M, et al. ; SPCG-4 Investigators. Radical
prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med.
2011 May 5;364(18):1708-17.
Vickers AJ, Cronin AM, Björk T, et al. Prostate specific antigen concentration at
age 60 and death or metastasis from prostate cancer: case-control study. BMJ.
2010 Sep 14;341:c4521.
Rosario DJ, Lane JA, Metcalfe C, et al. Short term outcomes of prostate biopsy in
men tested for cancer by prostate specific antigen: prospective evaluation within
ProtecT study. BMJ. 2012 Jan 9;344:d7894.
Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostatespecific antigen screening: importance of methods and context. J Natl Cancer Inst.
2009 Mar 18;101(6):374-83. Epub 2009 Mar 10.